ExodusPoint Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

ExodusPoint Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.68M	Sell	110,185 -170,049	-61%	-$9.91M	0.05%	349
2025 Q4	$15.1M	Buy	+280,234	New	+$13.5M	0.12%	154
2025 Q3	–	Sell	-51,047	Closed	-$2.36M	–	1554
2025 Q2	$2.36M	Buy	+51,047	New	+$2.51M	0.02%	681
2025 Q1	–	Sell	-342,315	Closed	-$19.4M	–	1488
2024 Q4	$19.4M	Buy	342,315 +202,426	+145%	+$11.3M	0.13%	130
2024 Q3	$7.24M	Buy	+139,889	New	+$6.56M	0.04%	302
2024 Q1	–	Sell	-101,652	Closed	-$5.22M	–	1500
2023 Q4	$5.22M	Buy	101,652 +43,255	+74%	+$2.27M	0.03%	333
2023 Q3	$3.39M	Sell	58,397 -163,721	-74%	-$10M	0.03%	488
2023 Q2	$14.2M	Sell	222,118 -381,907	-63%	-$25.6M	0.12%	175
2023 Q1	$41.9M	Buy	604,025 +377,684	+167%	+$26.6M	0.35%	33
2022 Q4	$16.3M	Buy	+226,341	New	+$17.1M	0.24%	97
2021 Q4	–	Sell	-234,125	Closed	-$13.9M	–	2180
2021 Q3	$13.9M	Buy	234,125 +199,709	+580%	+$13.2M	0.19%	126
2021 Q2	$2.3M	Buy	34,416 +2,614	+8%	+$170K	0.03%	612
2021 Q1	$2.01M	Sell	31,802 -37,719	-54%	-$2.35M	0.03%	569
2020 Q4	$4.31M	Buy	+69,521	New	+$4.27M	0.04%	291
2020 Q3	–	Sell	-278,398	Closed	-$16.4M	–	1759
2020 Q2	$16.4M	Buy	278,398 +171,879	+161%	+$10.3M	0.42%	29
2020 Q1	$5.94M	Buy	+106,519	New	+$6.51M	0.33%	52
2019 Q4	–	Sell	-61,528	Closed	-$3.12M	–	1541
2019 Q3	$3.12M	Buy	+61,528	New	+$2.89M	0.11%	165
2019 Q2	–	Sell	-75,294	Closed	-$3.51M	–	1109
2019 Q1	$3.59M	Buy	75,294 +68,562	+1,018%	+$3.42M	0.27%	65
2018 Q4	$350K	Buy	+6,732	New	+$362K	0.02%	180

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ExodusPoint Capital Management's BMY Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 61% in Q1 2026, selling an estimated $9.91M and leaving 110,185 shares worth $6.68M. The position accounts for 0.05% of the portfolio, ranked #349.

ExodusPoint Capital Management first reported a position in BMY in Q4 2018 and has held it in 19 quarters since. The position peaked at $41.9M in Q1 2023. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

ExodusPoint Capital Management held 110,185 shares of Bristol-Myers Squibb worth $6.68M as of Q1 2026.
ExodusPoint Capital Management sold 170,049 Bristol-Myers Squibb shares in Q1 2026, an estimated $9.91M.
Bristol-Myers Squibb made up 0.05% of ExodusPoint Capital Management's portfolio in Q1 2026, its #349 holding.
ExodusPoint Capital Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 19 quarters since.
ExodusPoint Capital Management's Bristol-Myers Squibb position peaked at $41.9M in Q1 2023.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.